Full Text View
Tabular View
No Study Results Posted
Related Studies
MP470 in Treating Patients With Unresectable or Metastatic Solid Tumor or Lymphoma
This study has been terminated.
( Withdrawn as trial was never activated by SuperGen )
Study NCT00504205   Information provided by National Cancer Institute (NCI)

First Received on July 17, 2007.   Last Updated on March 16, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Lymphoma
Additional conditions recognized in this trial
Lymphoma, Large-Cell, Immunoblastic
Lymphoma, Non-Hodgkin
More general conditions related to this trial
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms
Neoplasms by Histologic Type
Interventions listed in this trial
laboratory biomarker analysis
pharmacological study
positron emission tomography
Sponsors listed in this trial
Astex Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services